Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_provenance.
- NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_provenance.
- NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_assertion evidence source_evidence_literature NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_provenance.
- NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_assertion SIO_000772 8603636 NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_provenance.
- NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_assertion wasDerivedFrom befree-2016 NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_provenance.
- NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_assertion wasGeneratedBy ECO_0000203 NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_provenance.
- befree-2016 importedOn "2016-02-19" NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_provenance.